Reduced Custom Duty to nil and GST to 5% on three anti-cancer medicines, effective October 10, 2024, requiring price revisions by manufacturers by Lexplosion | Nov 4, 2024 | Central, OPS, PharmaceuticalsThe National Pharmaceutical Pricing Authority (“NPPA”) has issued a Notification informing that... Read More
Union Health Ministry mandates registration of Clinical Research Organizations under New Drugs and Clinical Trials Amendment Rules, effective 1st April, 2025 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Union Health Ministry has notified the New Drugs and Clinical Trials (Amendment) Rules, 2024... Read More
Pharmaceuticals Department notifies revisions to sub-scheme ‘Revamped Pharmaceutical Technology Upgradation Assistance Scheme’: Increases incentive cap and simplifies application process for Pharma MSMEs by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsDepartment of Pharmaceuticals has notified modifications under the sub-scheme “Revamped... Read More
CDSCO mandates online-only submissions in Form-44 for veterinary drugs through SUGAM portal, ending offline options by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsWith a view to streamline the regulatory submission procedure, the veterinary division of the... Read More
CDSCO invites public comments on Draft Guidelines for Good Clinical Practices till 12th October 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Central Drugs Standard Control Organization (“CDSCO”) has invited comments/suggestions on... Read More
NPPA revises ceiling price of Chloroquine (150mg) tablet price to Rs. 1.33 per tablet; manufacturers directed to align pricing with ceiling price by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe National Pharmaceutical Pricing Authority (“NPPA”), after reviewing the Wholesale... Read More